Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.920 | 0.950 | 0.030 |
Shares | 99.090 | 99.090 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.976 | 21.938 |
Price to Book | 4.489 | 4.163 |
Price to Sales | 2.339 | 2.423 |
Price to Cash Flow | 20.179 | 17.252 |
Dividend Yield | 1.368 | 1.315 |
5 Years Earnings Growth | 11.089 | 13.239 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.26 | 752.6 | -2.12% | |
AstraZeneca | GB0009895292 | 6.30 | 11,042.0 | +0.18% | |
J&J | US4781601046 | 6.21 | 158.24 | -1.18% | |
Roche Holding Participation | CH0012032048 | 5.91 | 272.30 | -0.29% | |
Eli Lilly | US5324571083 | 5.43 | 806.14 | -1.56% | |
Lonza Group | CH0013841017 | 4.58 | 542.40 | -1.20% | |
Thermo Fisher Scientific | US8835561023 | 4.28 | 555.47 | -0.44% | |
AbbVie | US00287Y1091 | 3.69 | 200.47 | -1.51% | |
UnitedHealth | US91324P1021 | 3.40 | 557.77 | -1.72% | |
Pfizer | US7170811035 | 2.88 | 27.76 | -1.17% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 112.19B | 23.38 | 16.09 | 15.50 | ||
DNB Teknologi NOK | 77.91B | 28.90 | 18.52 | 23.90 | ||
NO0010801913 | 77.91B | 24.89 | 17.50 | 23.61 | ||
Pensjonsprofil 80 | 50.23B | 14.43 | 7.06 | 8.67 | ||
DNB Global IV | 40.88B | 23.11 | 16.22 | 15.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review